BioCardia Inc
For the period ended Dec 31, 2023. Filed Mar 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 27, 2024
BCDA$0.90+6.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
BIOCARDIA, INC.
Consolidated Balance Sheets
(In thousands, except share and per share amounts)
| December 31, | December 31, | |
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $1,103 | $7,363 |
| Accounts receivable, net of allowance for doubtful accounts of $34 and $11 as of December 31, 2023 and 2022 | 63 | 201 |
| Prepaid expenses and other current assets | 295 | 300 |
| Total current assets | 1,461 | 7,864 |
| Property and equipment, net | 94 | 170 |
| Operating lease right-of-use asset, net | 1,261 | 1,588 |
| Other assets | 171 | 171 |
| Total assets | $2,987 | $9,793 |
| Liabilities and Stockholders’ Equity (Deficit) | ||
| Current liabilities: | ||
| Accounts payable | $890 | $683 |
| Accrued expenses and other current liabilities | 2,385 | 2,246 |
| Deferred revenue | — | 341 |
| Operating lease liability - current | 333 | 315 |
| Total current liabilities | 3,608 | 3,585 |
| Operating lease liability - noncurrent | 982 | 1,316 |
| Total liabilities | 4,590 | 4,901 |
| Commitments and contingencies (Notes 2, 5 and 13) | ||
| Stockholders’ equity (deficit): | ||
| Preferred stock, $0.001 par value, 25,000,000 shares authorized and no shares issued and outstanding as of December 31, 2023 and 2022 | — | — |
| Common stock, $0.001 par value, 100,000,000 shares authorized, 23,666,534 and 20,076,773 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 24 | 20 |
| Additional paid-in capital | 150,548 | 145,476 |
| Accumulated deficit | (152,175) | (140,604) |
| Total stockholders’ equity (deficit) | (1,603) | 4,892 |
| Total liabilities and stockholders’ equity (deficit) | $2,987 | $9,793 |
See accompanying notes to the consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.